New TMA (4,6,4'-Trimethyl angelicin) Analogues as Anti-Inflammatory Agents in the Treatment of Cystic Fibrosis Lung Disease.

MLA

Tupini, Chiara, et al. “New TMA (4,6,4’-Trimethyl Angelicin) Analogues as Anti-Inflammatory Agents in the Treatment of Cystic Fibrosis Lung Disease.” International Journal of Molecular Sciences, vol. 23, no. 22, Nov. 2022. EBSCOhost, https://doi.org/10.3390/ijms232214483.

APA

Tupini, C., Chilin, A., Rossi, A., De Fino, I., Bragonzi, A., D’Aversa, E., Cosenza, L. C., Vaccarin, C., Sacchetti, G., Borgatti, M., Tamanini, A., Dechecchi, M. C., Sanvito, F., Gambari, R., Cabrini, G., & Lampronti, I. (2022). New TMA (4,6,4’-Trimethyl angelicin) Analogues as Anti-Inflammatory Agents in the Treatment of Cystic Fibrosis Lung Disease. International Journal of Molecular Sciences, 23(22). https://doi.org/10.3390/ijms232214483

Chicago

Tupini, Chiara, Adriana Chilin, Alice Rossi, Ida De Fino, Alessandra Bragonzi, Elisabetta D’Aversa, Lucia Carmela Cosenza, et al. 2022. “New TMA (4,6,4’-Trimethyl Angelicin) Analogues as Anti-Inflammatory Agents in the Treatment of Cystic Fibrosis Lung Disease.” International Journal of Molecular Sciences 23 (22). doi:10.3390/ijms232214483.